For millions of vulnerable people, COVID-19 is far from over – National Geographic

For millions of vulnerable people, COVID-19 is far from over – National Geographic

COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide – World Health Organization

COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide – World Health Organization

March 2, 2022

In the first year of the COVID-19 pandemic, global prevalence of anxiety and depression increased by a massive 25%, according to a scientific brief released by the World Health Organization (WHO) today. The brief also highlights who has been most affected and summarizes the effect of the pandemic on the availability of mental health services and how this has changed during the pandemic.

Concerns about potential increases in mental health conditions had already prompted 90% of countries surveyed to include mental health and psychosocial support in their COVID-19 response plans, but major gaps and concerns remain.

The information we have now about the impact of COVID-19 on the worlds mental health is just the tip of the iceberg, said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. This is a wake-up call to all countries to pay more attention to mental health and do a better job of supporting their populations mental health.

Multiple stress factors

One major explanation for the increase is the unprecedented stress caused by the social isolation resulting from the pandemic. Linked to this were constraints on peoples ability to work, seek support from loved ones and engage in their communities.

Loneliness, fear of infection, suffering and death for oneself and for loved ones, grief after bereavement and financial worries have also all been cited as stressors leading to anxiety and depression. Among health workers, exhaustion has been a major trigger for suicidal thinking.

Young people and women worst hit

The brief, which is informed by a comprehensive review of existing evidence about the impact of COVID-19 on mental health and mental health services, and includes estimates from the latest Global Burden of Disease study, shows that the pandemic has affected the mental health of young people and that they are disproportionally at risk of suicidal and self-harming behaviours. It also indicates that women have been more severely impacted than men and that people with pre-existing physical health conditions, such as asthma, cancer and heart disease, were more likely to develop symptoms of mental disorders.

Data suggests that people with pre-existing mental disorders do not appear to be disproportionately vulnerable to COVID-19 infection. Yet, when these people do become infected, they are more likely to suffer hospitalization, severe illness and death compared with people without mental disorders. People with more severe mental disorders, such as psychoses, and young people with mental disorders, are particularly at risk.

Gaps in care

This increase in the prevalence of mental health problems has coincided with severe disruptions to mental health services, leaving huge gaps in care for those who need it most. For much of the pandemic, services for mental, neurological and substance use conditions were the most disrupted among all essential health services reported by WHO Member States. Many countries also reported major disruptions in life-saving services for mental health, including for suicide prevention.

By the end of 2021 the situation had somewhat improved but today too many people remain unable to get the care and support they need for both pre-existing and newly developed mental health conditions.

Unable to access face-to-face care, many people have sought support online, signaling an urgent need to make reliable and effective digital tools available and easily accessible. However, developing and deploying digital interventions remains a major challenge in resource-limited countries and settings.

WHO and country action

Since the early days of the pandemic, WHO and partners have worked to develop and disseminate resources in multiple languages and formats to help different groups cope with and respond to the mental health impacts of COVID-19. For example, WHO produced a story book for 6-11-year-olds, My Hero is You, now available in 142 languages and 61 multimedia adaptations, as well as a toolkit for supporting older adults available in 16 languages.

At the same time, the Organization has worked with partners, including other United Nations agencies, international nongovernmental organizations and the Red Cross and Red Crescent Societies, to lead an interagency mental health and psychosocial response to COVID-19. Throughout the pandemic, WHO has also worked to promote the integration of mental health and psychosocial support across and within all aspects of the global response.

WHO Member States have recognized the impact of COVID-19 on mental health and are taking action. WHOs most recent pulse survey on continuity of essential health services indicated that 90% of countries are working to provide mental health and psychosocial support to COVID-19 patients and responders alike. Moreover, at last years World Health Assembly, countries emphasized the need to develop and strengthen mental health and psychosocial support services as part of strengthening preparedness, response and resilience to COVID-19 and future public health emergencies. They adopted the updated Comprehensive Mental Health Action Plan 2013-2030, which includes an indicator on preparedness for mental health and psychosocial support in public health emergencies.

Step up investment

However, this commitment to mental health needs to be accompanied by a global step up in investment. Unfortunately, the situation underscores a chronic global shortage of mental health resources that continues today. WHOs most recent Mental Health Atlas showed that in 2020, governments worldwide spent on average just over 2% of their health budgets on mental health and many low-income countries reported having fewer than 1 mental health worker per 100 000 people.

Dvora Kestel, Director of the Department of Mental Health and Substance Use at WHO, sums up the situation: While the pandemic has generated interest in and concern for mental health, it has also revealed historical under-investment in mental health services. Countries must act urgently to ensure that mental health support is available to all.


Read the rest here: COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide - World Health Organization
China Weighs Methods for Relaxing Zero-Covid-19 Grip: Bubbles, Drugs and New Messaging – The Wall Street Journal

China Weighs Methods for Relaxing Zero-Covid-19 Grip: Bubbles, Drugs and New Messaging – The Wall Street Journal

March 2, 2022

China, the last major country to stick with a zero-tolerance approach to Covid-19, is now actively exploring ways to loosen controls.

In preparation for a potential opening, Chinese officials are looking into the use of travel bubbles modeled on measures taken during the Winter Olympics, collecting data on new antiviral drugs and scouting sites abroad for future production of homegrown Chinese mRNA vaccines, according to people familiar with the matter.


See the rest here: China Weighs Methods for Relaxing Zero-Covid-19 Grip: Bubbles, Drugs and New Messaging - The Wall Street Journal
COVID-19 in South Dakota: 78 new cases; 6 new deaths; Active cases at 4,166 – KELOLAND.com

COVID-19 in South Dakota: 78 new cases; 6 new deaths; Active cases at 4,166 – KELOLAND.com

March 2, 2022

SIOUX FALLS, S.D. (KELO) The South Dakota Department of Health reported six COVID-19 deaths on Wednesday.

The COVID-19 death toll is now at 2,814 up from Tuesday (2,808). The deaths were three men and three women in the following age ranges: 40-49 (1); 60-69 (2); 70-79 (1) and 80+ (2). The deaths were reported in the following counties: Brown, Minnehaha (2), Turner, Tripp and Union Counties.

Active cases are now at 4,166, down from Tuesday (4,419).

For the week of Feb. 28, 50 of South Dakotas 66 counties are listed as having high or substantial community spread. High community spread is 100 cases or greater per 100,000 or a 10% or greater PCR test positivity rate.

There are now 148 people hospitalized due to COVID-19, up from Tuesday (147). Throughout the pandemic, there have been 10,569 total people who have been hospitalized.

There were 78 confirmed and probable COVID-19 cases reported.

The states total case count is now at 236,132, up from Tuesday (236,056). That total does not include at-home positive results as those are not required to be reported to the state.

The latest seven-day PCR test positivity rate for the state is 10.4% for Feb. 21 27.

The number of recovered cases is at 229,152.

There have been 1,494 Delta variant cases (B.1.617.2 and AY lineages) detected in South Dakota through sentinel monitoring. There have been 176 cases of the B.1.1.7 (Alpha variant), four cases of P.1. (Gamma variant) and two cases of the B.1.351 (Beta variant).

The number of Omicron cases is now at 705.

For COVID-19 vaccines, 71.23% the population 5-years-old and above has received at least one dose while 58.34% have completed the vaccination series. For booster doses, 32.05% of those eligible have completed their booster dose.

There have been 668,698 doses of the Pfizer vaccine administered, 466,791 of the Moderna vaccine and 37,479 doses of the Janssen vaccine.

There have been 173,924 persons who have completed two doses of Moderna. There have been 256,683 persons who have received two doses of Pfizer.

As for booster doses, 115,957 people have received a 3rd Pfizer shot, 89,050 people have received a 3rd Moderna dose and 2,647 have received a Janssen booster.


Excerpt from: COVID-19 in South Dakota: 78 new cases; 6 new deaths; Active cases at 4,166 - KELOLAND.com
Researchers at Yale Find Scientific Way to Predict Outcomes of COVID-19 in Patients – NBC Connecticut

Researchers at Yale Find Scientific Way to Predict Outcomes of COVID-19 in Patients – NBC Connecticut

March 2, 2022

Since COVID-19 hit our state two years ago, more than 10,000 residents have died, but what if there was a scientific way to predict who would live and who would die?

A team of researchers at Yale think they may be able to do that with 83 percent accuracy.

This all started when researchers ended up with a lot of data from patients at Yale New Haven Hospital who were admitted with severe cases of COVID-19.

"They had such a massive amount of the data, something like a total of 54 million cells on 168 or so patients," said Yale computer science professor Smita Krishnaswamy.

Researchers needed to find a way to analyze all of those cells so they teamed up with another group to use something called the multi-scale phate tool. It's a machine learning tool that is being developed at Yale.

It allowed them to see very intricate details of the data that other systems cannot and what they found was pretty big.

"What Smita's team found is that there are certain cell types that are more associated with mortality, and other cell types are protective of mortality," Yale School of Medicine professor of immunobiology Akiko Iwasaki said.

"So those cells that the team found to be most protective, were the so called lymphocytes, which are a subset of white blood cells that are geared towards fighting against infection," Iwasaki added. "The other extreme is that the team found that there were these granulocytes, which are this larger cells that are also white blood cells."

"What's actually seen in COVID patients is that these granulocytes secrete factors that can clog the blood vessels and, you know, damage the tissue itself and these granulocytes were found to be most associated with mortality," according to Iwasaki.

"I hadn't expected to find that one level one group of cells being protective. And then if you zoom in, there's some bad apples inside that are actually destroying the body so that was surprising for me," Krishnaswamy added.

Now that they know which cells protect and which cells hurt, doctors might be able to improve upon COVID-19 treatments, vaccines and mores.

"So from this particular study, we already can see what cells types are associated with mortality, and we can separate the patients based on that alone. And that can sort of help the doctors, you know, learn about the patients earlier, to kind of give them treatments that are, you know, more aggressive, perhaps to help them," Akiko said.

Researchers think that this strategy can be used to predict outcomes for other types of infectious diseases, autoimmune diseases or even cancer. They're even studying this process for neurodegenerative diseases.


Original post:
Researchers at Yale Find Scientific Way to Predict Outcomes of COVID-19 in Patients - NBC Connecticut
FDA warns about unauthorized versions of rapid COVID-19 tests – MedTech Dive

FDA warns about unauthorized versions of rapid COVID-19 tests – MedTech Dive

March 2, 2022

Dive Brief:

All the affected tests appear to be products originally destined for the European market. The packaging of the Acontest carries a CE mark, while the packaging of the SD Biosensor test includes a statement about how long it takes to deliver results that is translated into English, Spanish, French and Portuguese. Celltrion's recall notice confirms its problem relates to the importation of the European version of its test.

After discovering what was happening, Celltrion"sent cease and desist letter to distributors who were illegally distributing non-EUA product in the U.S."and "demanded return of all EU product from distributors'inventory and demanded removal of all EU DiaTrust Tests from the U.S."The company has also written to "all EU distributors warning against diversion and obtaining confirmation that distributors understand limitations on distribution only within the EU."

The importation of European tests into the U.S. potentially reflects an imbalance in the availability of rapid antigen kits. While the U.K. faced a short period in which government-provided rapid antigen tests were in and out of stock, access to the kits has generally been less constrained in Europe than in the U.S., creating incentives for distributors to divert them to the place where demand exceeded supply.

Those diversions have brought tests that lack FDA authorization into the U.S. FDA warned that the tests carry a risk of false negatives and false positives and advised healthcare providers who have used the kits in the past two weeks to consider retesting their patients with an authorized or cleared alternative if they suspect an inaccurate result.

The agency has not received reports of injuries, adverse health consequences or death associated with any of the tests, and categorized the Celltrion recall as a Class II event. FDA is yet to publish details of the recalls by Acon and SD Biosensor.

Since late January, FDA has issued a flurry of notices about rapid COVID-19 tests with public warnings about unauthorized tests including E25Bioand Empowered Diagnostics. The agency classified Empowered Diagnostics' recall as a Class I event, although at the time FDA said there were no reports of adverse health consequences or death from use of the tests.


Read the original here: FDA warns about unauthorized versions of rapid COVID-19 tests - MedTech Dive
How COVID-19 Immunity Holds Up Over Time – National Institutes of Health (.gov)

How COVID-19 Immunity Holds Up Over Time – National Institutes of Health (.gov)

March 2, 2022

Posted on March 1st, 2022 by Lawrence Tabak, D.D.S., Ph.D.

More than 215 million people in the United States are now fully vaccinated against the SARS-CoV-2 virus responsible for COVID-19 [1]. More than 40 percentmore than 94 million peoplealso have rolled up their sleeves for an additional, booster dose. Now, an NIH-funded study exploring how mRNA vaccines are performing over time comes as a reminder of just how important it will be to keep those COVID-19 vaccines up to date as coronavirus variants continue to circulate.

The results, published in the journal Science Translational Medicine, show that people who received two doses of either the Pfizer or Moderna COVID-19 mRNA vaccines did generate needed virus-neutralizing antibodies [2]. But levels of those antibodies dropped considerably after six months, suggesting declining immunity over time.

The data also reveal that study participants had much reduced protection against newer SARS-CoV-2 variants, including Delta and Omicron. While antibody protection remained stronger in people whod also had a breakthrough infection, even that didnt appear to offer much protection against infection by the Omicron variant.

The new study comes from a team led by Shan-Lu Liu at The Ohio State University, Columbus. They wanted to explore how well vaccine-acquired immune protection holds up over time, especially in light of newly arising SARS-CoV-2 variants.

This is an important issue going forward because mRNA vaccines train the immune system to produce antibodies against the spike proteins that crown the surface of the SARS-CoV-2 coronavirus. These new variants often have mutated, or slightly changed, spike proteins compared to the original one the immune system has been trained to detect, potentially dampening the immune response.

In the study, the team collected serum samples from 48 fully vaccinated health care workers at four key time points: 1) before vaccination, 2) three weeks after the first dose, 3) one month after the second dose, and 4) six months after the second dose.

They then tested the ability of antibodies in those samples to neutralize spike proteins as a correlate for how well a vaccine works to prevent infection. The spike proteins represented five major SARS-CoV-2 variants. The variants included D614G, which arose very soon after the coronavirus first was identified in Wuhan and quickly took over, as well as Alpha (B.1.1.7), Beta (B.1.351), Delta (B.1.617.2), and Omicron (B.1.1.529).

The researchers explored in the lab how neutralizing antibodies within those serum samples reacted to SARS-CoV-2 pseudoviruses representing each of the five variants. SARS-CoV-2 pseudoviruses are harmless viruses engineered, in this case, to bear coronavirus spike proteins on their surfaces. Because they dont replicate, they are safe to study without specially designed biosafety facilities.

At any of the four time points, antibodies showed a minimal ability to neutralize the Omicron spike protein, which harbors about 30 mutations. These findings are consistent with an earlier study showing a significant decline in neutralizing antibodies against Omicron in people whove received the initial series of two shots, with improved neutralizing ability following an additional booster dose.

The neutralizing ability of antibodies against all other spike variants showed a dramatic decline from 1 to 6 months after the second dose. While there was a marked decline over time after both vaccines, samples from health care workers whod received the Moderna vaccine showed about twice the neutralizing ability of those whod received the Pfizer vaccine. The data also suggests greater immune protection in fully vaccinated healthcare workers whod had a breakthrough infection with SARS-CoV-2.

In addition to recommending full vaccination for all eligible individuals, the Centers for Disease Control and Prevention (CDC) now recommends everyone 12 years and up should get a booster dose of either the Pfizer or Moderna vaccines at least five months after completing the primary series of two shots [3]. Those whove received the Johnson & Johnson vaccine should get a booster at least two months after receiving the initial dose.

While plenty of questions about the durability of COVID-19 immunity over time remain, its clear that the rapid deployment of multiple vaccines over the course of this pandemic already has saved many lives and kept many more people out of the hospital. As the Omicron threat subsides and we start to look forward to better days ahead, it will remain critical for researchers and policymakers to continually evaluate and revise vaccination strategies and recommendations, to keep our defenses up as this virus continues to evolve.

References:

[1] COVID-19 vaccinations in the United States. Centers for Disease Control and Prevention. February 27, 2022.

[2] Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Evans JP, Zeng C, Carlin C, Lozanski G, Saif LJ, Oltz EM, Gumina RJ, Liu SL. Sci Transl Med. 2022 Feb 15:eabn8057.

[3] COVID-19 vaccine booster shots. Centers for Disease Control and Prevention. Feb 2, 2022.

Links:

COVID-19 Research (NIH)

Shan-Lu Liu (The Ohio State University, Columbus)

NIH Support: National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development

Related

Posted In: News

Tags: antibodies, booster shot, CDC, coronavirus, COVID-19, COVID-19 vaccine, Delta variant, immunity, Moderna, Moderna vaccine, mRNA vaccines, neutralizing antibodies, Omicron variant, pandemic, Pfizer, Pfizer/BioNTech vaccine, pseudovirus, SARS-CoV-2, vaccines, variants


Original post: How COVID-19 Immunity Holds Up Over Time - National Institutes of Health (.gov)
COVID-19 restrictions ease, but Ukraine war is ramping up. Whats that mean for travelers? | Sandy Fenton – PennLive

COVID-19 restrictions ease, but Ukraine war is ramping up. Whats that mean for travelers? | Sandy Fenton – PennLive

March 2, 2022

Here it is, the end of February and Im writing my first travel column of 2022. I was excited to give you lots of new and positive travel updates, especially concerning COVID-19. But now the world of travel is sadly shaken up again, this time due to the Russian invasion of Ukraine.

So before I get into all of my COVID-19-related news, here is whats happening today in the world of cruise travel.

As a whole, the travel industry is on a watch-and-wait directive while actively monitoring the situation. Ocean and river cruise lines are prepared to alter any Baltic, Russian and Eastern Europe itineraries (the same holds true for land-tour operators). With that said, NCL, Oceania Cruises, Regent Seven Seas, Viking and Windstar Cruises have removed St. Petersburg, Russia, from all 2022 sailings due to the ongoing war. New ports-of-calls will be announced soon.

A new start-up cruise line (adventure luxury), Atlas Ocean Voyages, announced they are adjusting two late summer Baltic itineraries and will replace them with trips to Kotka and Marrehamn, in Finland. Guests already booked for this spring and summer should expect changes and keep in contact with their travel agent. Thus far, consumer cancellations appear to be few.

Viking River Cruises have cancelled all 2022 departures from Kyiv, Ukraine, the Black Sea and Bucharest, Romania. Guests are being contacted directly with alternative river cruise options and rescheduling venues available.

Meanwhile, with new COVID-19 cases going down daily, combined with restrictions easing or being eliminated, people are ready to travel again -- and in a big way. Premium and luxury travel appear to be the most popular -- and consumers are spending big money on luxurious hotel rooms, cruise suites, fine wining and dining experiences, and longer stays.

Is it spring fever or pandemic fatigue?

High-end hotels and resorts, plus both river and cruise lines are not just selling out, some are already at pre-pandemic capacity.

Will the demand and the money continue? No one knows for sure, but for now, thats the reality.

For example, Florida tourism demand is at an all-time high and the Walt Disney Company theme parks are filled with their guests spending more money per person than they were in 2019.

Viking River Cruises will be launching their brand new Viking Mississippi river ship this August and according to Vikings Senior Vice President Michele Saegesser, sailings for 2022 and 2023 are mostly sold out. She recommends booking for 2024, or if you are flexible, tell your travel agent to keep you on a cancellation/wait list for this year and next. (Another option would be to look into American Cruise Lines Mississippi sailings, but know this will be a completely different style.)

Regent Seven Seas Cruises Director of Business Development for North America Eric Schmit said their luxury travelers are not just booking back-to-back and longer cruises, they are booking their next cruises while onboard, with the most luxurious suites selling out first. Space is tight going into this summer and fall -- and 2023 is filling quickly.

On Feb. 18, most of the cruise industry opted into the updated (and voluntary) CDC & Preventions COVID-19 program, which asks cruise lines to report vaccinated status of crew and passengers on each ship so results can be tracked. The CDC also downgraded their cruise line health warning from Level 4 to Level 3. Beginning March 1 most cruise ships will install a masks onboard recommended, but not required policy that in itself is a dealmaker for many potential travelers.

Cruise lines moving forward are committed to adjust health & safety protocols to ensure all onboard guests, crew and port destinations are protected. All officers and crew will still be masked, and all adult guests plus some children ages 10 and up will need to be fully vaccinated, and some will require boosters -- be sure to get expert advice from a travel agent before committing.

So what else is new for this spring?

Without a doubt, drive-to vacation getaways and road trips continue to soar in popularity. Were lucky to have so many wonderful destinations here in Pennsylvania. As Michael Chapaloney, Pa. Tourism Executive Director, always says, Pennsylvania has an embarrassment of riches. Go to VisitPA.com for all information on what to see, do, where to eat and where to sleep. You can easily discover your own backyard on a budget that works.

Direct, nonstop flights from Harrisburg International Airport offer many desirable vacations to Florida, Myrtle Beach and Nashville. Travelers want to keep their vacations uncomplicated with less time in airports and more time to experience new places, explore and unplug.

The three Is -- Iceland, Italy and Ireland -- are open and ready to welcome Americans back. Beginning this summer Icelandair will fly from Baltimore to Reykjavik, Iceland, and new stops in Europe and Greenland have just been added.

Many domestic and international airlines are offering spring savings for popular and off-the-beaten-path destinations now and throughout the summer.

Every day more countries are lifting certain COVID-19 restrictions. Just this week, Israel, the Bahamas, the Dominican Republic, the Cayman Islands, Jamaica and Australia have all altered their coronavirus restrictions. The list will continue to grow, so do some research before you travel.

In closing, many of us are starting to see COVID-19 not as a travel deterrent, but rather a do it now motivator, because who knows what may be lurking just around the bend. A professional and experienced travel agent should be your new best friend when planning your long-awaited vacation.

If you are planning to travel out of the country, be sure you renew your passport six months prior to the expiration date and verify that your passport is valid for at least six months after your return to the United States. Keep updated with international travel news, particularly in regards to Baltic and Eastern European ocean, river and land tour information.

Be informed, be prepared and travel well.

Lets Talk Travel hosted by Sandy Fenton is broadcast Saturdays 11am to noon on iHeartRadios WHP580. For more information, go to whp580.com and click on the link to Lets Talk Travel.


See more here:
COVID-19 restrictions ease, but Ukraine war is ramping up. Whats that mean for travelers? | Sandy Fenton - PennLive
Covid Invades Cells in the Penis and Testicles of Monkeys, Study Says – The New York Times

Covid Invades Cells in the Penis and Testicles of Monkeys, Study Says – The New York Times

March 2, 2022

The coronavirus may infect tissue within the male genital tract, new research on rhesus macaques shows. The finding suggests that symptoms like erectile dysfunction reported by some Covid patients may be caused directly by the virus, not by inflammation or fever that often accompany the disease.

The research demonstrated that the coronavirus infected the prostate, penis, testicles and surrounding blood vessels in three male rhesus macaques. The monkeys were examined with whole body scans specially designed to detect sites of infection.

Scientists who expected to find the coronavirus in spots like the lungs but did not know where else they would find it were somewhat surprised by the discovery.

The signal that jumped out at us was the complete spread through the male genital tract, said Thomas Hope, the papers senior author and a professor of cell and developmental biology at Northwestern University Feinberg School of Medicine in Chicago. We had no idea we would find it there.

When his team initially reviewed a scanned image from the first animal, one of the scientists asked, What sex was the animal again? Dr. Hope recalled.

I said, I think female. She said, I dont think its a female. I went down to the bottom of the image, which was almost cut off, and the testes were brightly lit up. And the signal in the penis was off the radar, Dr. Hope said.

The paper was based on findings in just three monkeys, but the findings were consistent, Dr. Hope said. The study has not yet been peer reviewed for publication in a journal, and was posted Monday on the site bioRxiv.

The work was carried out at the Tulane National Primate Research Center in Louisiana. The researchers do not know whether the monkeys had symptoms corresponding to the viral infection of the male genital tract, such as low testosterone levels, low sperm counts, pain or sexual dysfunction, Dr. Hope said.

About 10 to 20 percent of men infected with the coronavirus have symptoms linked to male genital tract dysfunction, studies have reported.

Men infected with the virus are three to six times as likely as others to develop erectile dysfunction, believed to be an indicator of so-called long Covid.

Patients have also reported symptoms such as testicular pain, reduced sperm counts and reduced sperm quality, decreased fertility and hypogonadism, a condition in which the testes produce insufficient amounts of testosterone, leading to low sex drive, sexual dysfunction and reduced fertility.

Vaccine protection in adolescents. Five months after immunization, two doses of the Pfizer vaccine appeared to offer virtually no defense against moderate illnesscaused by Omicron among adolescents aged 12 to 17 years, according to new C.D.C. data. Booster shots, however, dramatically increased the protection.

Other viruses are known to take a toll on fertility, Dr. Hope noted. Mumps is most famous historically, for causing sterility, he said. The Zika virus goes to the testes and infects the testes, and Ebola can also do that.

Even if just a small fraction of men experience such complications after a coronavirus infection, millions may suffer from impaired sexual and reproductive health in the aftermath of the pandemic, simply because the virus has infected so many people around the world, Dr. Hope warned.

He urged men to get vaccinated, and to seek a medical evaluation if they are concerned about their sexual or reproductive health.

The positron emission tomography technology that was used in the new study was designed to identify the sites of coronavirus infection in a living animal. The technology makes it possible to do repeated, sequential scanning of an animal, tracking how the virus works its way through the body and how it is cleared.

Dr. Hope next plans to determine whether the testicles are a reservoir for the coronavirus, as has been hypothesized by some scientists. He will also look at whether the virus infects tissue in the female reproductive system.

The hope is to use the information to develop treatments that will mitigate the pandemics impact on fertility. The scans could also potentially detect the location of the virus in patients and help tailor treatments appropriately.


See the rest here:
Covid Invades Cells in the Penis and Testicles of Monkeys, Study Says - The New York Times
Biden outlines COVID plans, says it’s time to return to work – ABC News

Biden outlines COVID plans, says it’s time to return to work – ABC News

March 2, 2022

President Joe Biden says its time for Americans to get back to work and he's announcing new efforts to allow people to return to normal activities safely after two years of pandemic disruptions

By ZEKE MILLER Associated Press

March 2, 2022, 4:37 AM

4 min read

WASHINGTON -- President Joe Biden declared Tuesday that it's time for Americans to get back to work as he announced new efforts to allow people to return to normal activities safely after two years of pandemic disruptions.

Biden used his State of the Union address to announce that his administration was launching a test-to-treat initiative to provide free antiviral pills at pharmacies to those who test positive for the virus.

He also highlighted the progress made on the pandemic since last year, with a dramatic reduction in cases, readily-available vaccines and tests, and new therapeutics soon becoming more accessible.

Tonight, I can say we are moving forward safely, back to more normal routines, Biden said. Its time for Americans to get back to work and fill our great downtowns again.

His comments come ahead of the White House release of a new National COVID-19 Preparedness Plan on Wednesday. The White House said it would be a roadmap that will enable us to move forward safely, and sustain and build on the progress weve made over the past 13 months.

In his remarks Tuesday, Biden said that in addition to starting the new antiviral initiative, his administration would allow people in the U.S. to order another round of free tests from the government.

An antiviral pill from Pfizer has been shown to reduce the risk of hospitalization from COVID-19 by 90%. By the end of the month, the administration says, 1 million pills will be available, with double that ready for use in April.

A White House official said the test-to-treat plan will initially roll out in hundreds of pharmacies across the country, including CVS, Walgreens, and Kroger locations. Those who test positive at the sites will be able to obtain the antiviral pills on the spot for immediate use.

Biden said that starting next week, the administration would make available four more free tests to U.S. households through COVIDTests.gov, which has sent more than 270 million free tests to nearly 70 million households since it launched in mid-January.

COVID-19 cases have fallen to their lowest level since last summer in recent weeks, after a winter spike from the highly-transmissible omicron variant. Deaths, though, which lag cases by weeks, are still elevated, with an average of nearly 1,700 people dying in the U.S. each day. U.S. officials emphasize that most instances of serious illnesses and death in the U.S. occur among those who are unvaccinated or who have not received a booster dose of the vaccines.

Earlier Tuesday, Biden extended the federal governments 100% reimbursement of COVID-19 emergency response costs to states, tribes and territories through July 1, the White House announced Tuesday.

White House COVID-19 coordinator Jeff Zients informed governors on a conference call that Biden is approving the extension of Federal Emergency Management Agency support to help continue FEMA-backed efforts like vaccination clinics, mass testing sites and surging hospital resources to deal with local case spikes.

FEMAs priority throughout the response to COVID-19 has been to coordinate and provide the necessary resources and personnel states, tribes and territories need to adequately respond to the pandemic, FEMA Administrator Deanne Criswell said. Todays extension of the 100% cost-share through July 1, 2022, builds on our efforts to assist impacted communities across state and federal levels.

The extension through the first half of the year is a sign that the White House continues to see a need for federal resources in combating COVID-19 even as Biden tries to guide the country to live with the coronavirus while case counts recede.

Recent examples of FEMA funding include $1.2 million given to Ball State University in Indiana last month to cover on-campus testing and $91.8 million to Wisconsin to reimburse for COVID-19 testing costs and surge staffing in treatment centers.

Biden, a Democrat, first signed an order directing FEMA to cover 100% of state emergency costs related to the coronavirus on his second day in office through September 2021. He subsequently extended it to the end of 2021 and again through April 1.


Go here to read the rest: Biden outlines COVID plans, says it's time to return to work - ABC News
Illinois Coronavirus Updates: Top Doc to Leave Post, New Study on COVID and Fertility – NBC Chicago

Illinois Coronavirus Updates: Top Doc to Leave Post, New Study on COVID and Fertility – NBC Chicago

March 2, 2022

Illinois' top doctor has announced she will leave her post as the leader of the state's health department this month.

Her announcement comes as health officials say Illinois is entering the "next phase" of the coronavirus pandemic, with masking and vaccine restrictions being lifted in both Chicago and across the state.

Here's what you need to know about the coronavirus pandemic across Illinois today:

More free COVID tests from the government will soon become available, even for those who already received their first shipment, President Joe Biden announced during his State of the Union address.

In his remarks Tuesday, Biden said that in addition to starting a new antiviral initiative, his administration would allow people in the U.S. to order another round of free tests from the government.

Read more here.

After Tuesday's announcement that Illinois' top doctor would be leaving her position later this month, the state's Department of Public Health Director Director Dr. Ngozi Ezike detailed her next focus.

In an emotional address Tuesday, Ezike thanked Illinoisans for allowing her to lead the state through a global pandemic and said it's time for her to make her family a priority after a number of "sacrifices" the past two years.

Read more here.

A COVID-19 infection has the ability to reach the male genital tract, causing health problems in the penis, testicles and prostate, according to a new study from Northwestern Medicine.

The study found that the coronavirus infection caused testicular pain, erectile dysfunction, reduced sperm count and decreased fertility in a number of subjects.

Northwestern warned that "millions" of men could be affected by the results of the study and that men previously infected with COVID should "evaluate their sexual health."

Read more here.

Illinois Department of Public Health Director Dr. Ngozi Ezike will be leaving her position later this month after serving three years in the role, Gov. J.B. Pritzker announced Tuesday.

Ezike will serve her last day as Illinois' top doctor on March 14. Dr. Amaal Tokars, who is currently the assistant director of IDPH, will serve as interim director as a nationwide search is launched to find a permanent replacement, according to the governor's office.

In announcing her departure, Pritzker proclaimed Tuesday Dr. Ngozi Ezike Day in Illinois, acknowledging her role in the state's fight against the coronavirus pandemic.

"No number of sleepless nights and endless days could wear down her commitment to think first and foremost of Illinois' most vulnerable," Pritzker said. "I ran for office, I ran for office. She did not. But throughout the crisis, she has stood beside me every step of the way. I am not putting it lightly when I say that she has had one of the hardest jobs in the world. There is something particularly heroic about the service of an extraordinary individual who did not seek greatness, but found it anyway."

Read more here.

Five states and territories were dropped from Chicago's travel advisory Tuesday, bringing the city's warning list down to 47 states and one territory.

The city's health department announced the District of Columbia, Nebraska, Ohio, Puerto Rico, and the Virgin Islands all came off the advisory this week.

By next week, the city noted more than a dozen other locations could be removed.

Read more here.

Illinois Gov. J.B. Pritzker issued an updated executive order on Monday, officially ending mandatory masking in most indoor settings in the state.

According to the new order, masks will no longer be required inside of most businesses and will not be required inside of schools, but those institutions will be allowed to enact their own mask requirements at their own discretion, according to the order.

Read more here.


View post: Illinois Coronavirus Updates: Top Doc to Leave Post, New Study on COVID and Fertility - NBC Chicago